A multivariate logistic regression analysis in predicting malignancy for patients with ovarian tumors

Gynecologic Oncology

Volumn 68, Issue 3, 1998, Pages 256-262

  Hata, Kohkichi ^a   Akiba, Suminori ^b   Hata, Toshiyuki ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; B SCAN; BLOOD FLOW VELOCITY; CANCER STAGING; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; GRAY SCALE ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MENSTRUATION; MULTIVARIATE ANALYSIS; OVARY TUMOR; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY;

EID: 0032030898     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.4947     Document Type: Article

References (25)

1. Rottem S, Levit N, Thaler I, Yoffe N, Bronshtein M, Manor D, Brandes J M. Classification of ovarian lesions by high-frequency transvaginal sonography. J Clin Ultrasound. 18:1990;359-363.
2. Low R N, Carter W D, Saleh F, Sigeti J S. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Radiology. 195:1995;391-400.
3. Forstner R, Hricak H, Occhipinti K A, Powell C B, Frankel S D, Stern J L. Ovarian cancer: staging with CT and MR imaging. Radiology. 197:1995;619-626.
4. Granberg S, Norstrom A, Wikland M. Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol. 37:1990;224-229.
5. Zurawski V R Jr, Sjovall K, Schoenfeld D, Broderick S, Hall P, Bast R C Jr, Eklund G, Mattsson B, Connor R J, Prorok P C, Knapp R C, Einhorn N. Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities for single and serial determinations in testing for ovarian cancer. Gynecol Oncol. 36:1990;299-305.
6. Kurjak A, Zalud I, Alfrievic Z. Evaluation of adnexal masses with transvaginal color ultrasound. J Ultrasound Med. 10:1991;295-297.
7. Fleischer A C, Rodgers W H, Rao B K, Kepple D M, Worrell J A, Williams L. Assessment of ovarian tumor vascularity with transvaginal color Doppler sonography. J Ultrasound Med. 10:1991;563-568.
8. Tekay A, Jouppila P. Validity of pulsatility and resistance indices in classification of adnexal tumors with transvaginal color Doppler ultrasound. Ultrasound Obstet Gynecol. 2:1992;338-344.
9. Hata K, Hata T, Manabe A, Sugumura K, Kitao M. A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer. Obstet Gynecol. 80:1992;922-926.
10. Saldkevicius P, Valentin L, Marsal K. Transvaginal gray-scale and Doppler ultrasound examinations of the uterus and ovaries in healthy postmenopausal women. Ultrasound Obstet Gynecol. 6:1995;81-90.
11. Tekay, A, Jouppila P. Blood flow in benign ovarian tumors and normal ovaries during the follicular phase. Obstet Gynecol. 86:1995;55-59.
12. Hata K, Hata T, Kitao M. Intratumoral peak systolic velocity as a new possible predictor for detection of adnexal malignancy. Am J Obstet Gynecol. 172:1995;1496-1500.
13. Tailor A, Jurkovic D, Bourne T H, Natucci M, Collins W P, Campbell S. A comparison of intratumoral indices of blood flow velocity and impedance for the diagnosis of ovarian cancer. Ultrasound Med Biol. 22:1996;837-843.
14. Valentin L, Sladkevicius P, Marsal K. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet Gynecol. 83:1994;425-433.
15. Thompson R S, Trudinger B J, Cook C M. Doppler ultrasound waveform indices: A/B ratio, pulsatility index and Pourcelot ratio. Br J Obstet Gynaecol. 95:1998;581-588.
16. Hata K, Hata T, Senoh D, Makihara K, Aoki S, Takamiya O, Kitao M. Changes in ovarian arterial compliance during the human menstrual cycle assessed by Doppler ultrasound. Br J Obstet Gynaecol. 97:1990;163-166.
17. Preston D L, Lubin J H, Pierce D A. EPICURE: Risk Regression and Data Analysis Software. 1990;HiroSoft Intermational Corporation, Seattle.
18. Bourne T H, Campbell S, Reynolds K M, Whitehead M I, Hampson J, Royston R, Crayford T JB, Collins W P. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. Br J Med. 306:1993;359-363.
19. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 285:1971;1182-1186.
20. Folkman J, Merler E, Agernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 33:1971;275-288.
21. Reynolds K, Farzaneh F, Collins W P, Campbell S, Bourne T H, Lawton F, Moghaddam A, Harris A L, Bicknell R. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst. 86:1994;1234-1238.
22. Pauly J L, Schuller M G, Zelcer A A, Kriss T A, Gore S S, Germain M J. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst. 58:1977;1587-1590.
23. Moghaddam A, Bicknell R. Expression of platelet-derived endothelial cell growth factor inEscherichia coli. Biochemistry. 31:1992;12141-12146.
24. Hata K, Hata T, Collins W P. Association between the concentration of thymidine phosphorylase and ultrasound derived indices of blood flow in ovarian masses. Cancer. 80:1997;1079-1084.
25. Pettersson F. Annual Report on Gynecologic Cancer, FIGO 1994. 1995;Repro Printer AB, Stockholm.